NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Rheumatoid Arthritis Shared Decision Making
Rheumatoid Arthritis Shared Decision Making

NCT05530694

CompletedNA

Sponsor: VA Office of Research and Development

Conditions: Rheumatoid Arthritis

Interventions: Clinician communication training, Patient activation, RA Medication summary guide and RA Choice

Countries: United States

Shared decision making is the first overarching principle for the treat to target guidelines for rheumatoid arthritis (RA) and has been proposed as a potential mechanism to reduce health disparities, however there is little evidence to inform effective ways to implement this practice in the care of Veterans with RA. The purpose of this project is to evaluate the effectiveness of a multi-component shared decision making intervention on RA disease activity, adherence to RA medications and patient knowledge of RA. The proposed research will contribute to fundamental knowledge about how to effectively foster shared decision making across varied VA rheumatology clinical settings to improve patient disease outcomes and experience; and support clinicians to engage patients in meaningful ways with the ultimate goal to improve health, reduce disability, and eliminate disparities.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

Inclusion criteria for patient participants (Aims 1 \& 2):

* Meet administrative data definition of rheumatoid arthritis (see recruitment section)
* Receive rheumatology outpatient care at participating clinics and seen at least once in prior 12 months
* Age 18 years or older
* English speaking
* Moderate to high RA disease activity within 18 months prior to enrollment

Inclusion criteria for professional participants (Aims 1-3):

-Rheumatology attendings, fellows or advanced practice partners (nurse practitioners or physicians assistants) at the respective clinics

Inclusion criteria for non-clinician participants (Aim 3):

* Have held a leadership position within their respective institution for minimum of 12 months prior to enrollment
* Have worked in the rheumatology clinic setting at their respective institution for minimum of 12 months prior

Exclusion Criteria:

Exclusion criteria for patient participants (Aims 1 \& 2):

* Cognitive impairment
* Inability to speak

Exclusion criteria for professional participants (Aims 1-3):

-none

Exclusion criteria for non-clinician participants (Aim 3):

* Have held a leadership position within their respective institution for \<12 months
* Have worked in a clinic setting other than rheumatology
* Have worked in a clinic setting \<12 months
Locations (4)
  • San Francisco, California, United States
  • Wilmington, Delaware, United States
  • Portland, Oregon, United States
  • Philadelphia, Pennsylvania, United States